Asher Bio: Funding, Investors & Team (Sep 2026)
Asher Bio is a technology company that specializes in CFO Office transformation, profitability, and cost management, with a specific focus on improving immunotherapy for cancer. Established in 2019, the company is based in San Francisco, California.
Asher Bio has raised $55.0M across 1 funding round on record, the most recent a Series C of $55.0M announced in Apr 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Asher Bio Company Profile and Key Stats
Latest funding round on record: Apr 2024.
Asher Bio Funding Rounds
Asher Bio Founders and Leadership Team
No contact details are on record for this team yet.
Asher Bio Funding Compared to Other Biotechnology Startups
Asher Bio's latest round of $55.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Asher Bio in Biotechnology and San Francisco
Companies Similar to Asher Bio
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Asher Bio Funding FAQs
What does Asher Bio do?
Asher Bio is a technology company that specializes in CFO Office transformation, profitability, and cost management, with a specific focus on improving immunotherapy for cancer. Established in 2019, the company is based in San Francisco, California.
How much funding has Asher Bio raised?
Asher Bio has raised $55.0M across 1 round on record. The most recent is a Series C of $55.0M announced in Apr 2024.
When did Asher Bio last raise funding?
Asher Bio's most recent funding round on record is a Series C of $55.0M, announced in Apr 2024.
Who founded Asher Bio?
FundedIQ lists Andy Yeung (Founder) at Asher Bio.
Where is Asher Bio headquartered?
Asher Bio is based in San Francisco, California, United States.
How many employees does Asher Bio have?
Asher Bio is in the 11-50 employee band.
How does Asher Bio's funding compare to other Biotechnology startups?
Asher Bio's latest round of $55.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Asher Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Asher Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.